A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
PHASE2
Researchers are looking for a better way to treat men who have high-risk lo...
Status
Recruiting
Location
The Second Affiliated Hospital of Anhui Medical University
Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study
EARLY_PHASE1
Previous study findings suggest that the efficacy limitations of the neoadj...
Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
PHASE2
The PARIS-BIO study evaluates whether a novel genomic biomarker, the PCAI I...